Please login to the form below

Not currently logged in
Email:
Password:

opioid abuse

This page shows the latest opioid abuse news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Indivior’s drug to fight opioid addiction

FDA panel backs Indivior’s drug to fight opioid addiction

naloxone), another treatment for opioid dependence, and which raised the threat of low-cost copies reaching the market earlier than expected. ... Opioid abuse has become such an acute problem in the US that President Trump signed an executive order last

Latest news

  • FDA approves first substance use mobile medical application FDA approves first substance use mobile medical application

    Reset works by teaching users skills to increase their abstinence from substance abuse and keep them in outpatient therapy programmes. ... The trial did not demonstrate the effectiveness of using Reset for opioid abuse and the application is not licensed

  • Endo faces industry-first FDA call to pull its opioid painkiller Endo faces industry-first FDA call to pull its opioid painkiller

    abuse.”. Opioid overdoses killed 33, 000 Americans in 2015 - with half of those involving a prescription opioid. ... Previously Purdue Pharma’s opioid painkiller Oxycontin was removed from the market when an abuse-resistant form became available, but

  • A rock and a hard place A rock and a hard place

    Without the tamper-resistant packaging, critics argued that the FDA was ignoring the high potential for opioid abuse and the ramifications that came along with that. ... 51. Achievement of narrow targets and the potential for abuse are very different

  • FDA panel backs Pfizer and Teva abuse-resistant painkillers FDA panel backs Pfizer and Teva abuse-resistant painkillers

    FDA panel backs Pfizer and Teva abuse-resistant painkillers. Recommends long-acting opioid analgesics Troxyca ER and Vantrela ER for approval. ... An FDA advisory committee has recommended approval of two long-acting opioid analgesics from Teva and

  • FDA gives green light for opioid addiction implant FDA gives green light for opioid addiction implant

    He added: “ Opioid abuse and addiction have taken a devastating toll on American families. ... effective in the treatment of opioid use disorder than short-term detoxification programmes aimed at abstinence. “

More from news
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics